Integra LifeSciences Acquires Surgical Innovation Associates (SIA)

Integra LifeSciences Acquires ACell, Inc.

December 16, 2020

Medical Devices

Integra LifeSciences agreed to acquire regenerative-medicine company ACell, Inc. for $300 million upfront in cash plus up to $100 million in revenue-based milestones. The acquisition adds ACell's MatriStem porcine urinary bladder matrix platform to Integra's tissue technologies portfolio and is expected to close in Q1 2021, subject to customary conditions.

SI Solutions Acquires Radiological Solutions

February 5, 2026

Energy

SI Solutions, through its advanced engineering division Structural Integrity Associates (SIA), has acquired Radiological Solutions, Inc., a nuclear engineering partner that specializes in plant chemistry, radiological controls, radiation protection, and specialized monitoring equipment. The acquisition expands SIA's capabilities in nuclear chemistry, radiation management, emergency preparedness and equipment design and brings Radiological Solutions' team and expertise (based outside Chicago) into SI Solutions' PE-backed platform.

Integra LifeSciences Acquires Acclarent, Inc.

April 1, 2024

Medical Devices

Integra LifeSciences Holdings Corporation has completed its acquisition of Acclarent, Inc., a maker of ear, nose and throat (ENT) surgical devices. The transaction expands Integra’s product portfolio into the ENT device segment, adding approximately $1 billion to the company’s total addressable market and providing scale through Acclarent’s commercial and R&D capabilities.

Solventum Acquires Acera Surgical

December 23, 2025

Medical Devices

Solventum (NYSE: SOLV) has completed the acquisition of Acera Surgical, a privately held bioscience company that develops synthetic tissue matrices for regenerative wound care, for $725 million upfront plus up to $125 million in contingent payments. The deal expands Solventum's MedSurg and advanced wound care portfolio with Acera's synthetic electrospun matrix technology; Acera is expected to generate about $90 million in sales in 2025.

Smith & Nephew Acquires Integrity Orthopaedics

January 21, 2025

Medical Devices

Smith & Nephew has completed the acquisition of US-based Integrity Orthopaedics for up to $450 million, comprising an initial $225 million cash payment and up to $225 million in performance‑based payments over five years. The deal adds Integrity's FDA‑cleared Tendon Seam rotator cuff repair system to Smith & Nephew's sports medicine and shoulder portfolio to expand capabilities and accelerate growth under its RISE strategy.

Bimini Health Tech Subsidiary Acquires Ideal Implant, Inc. Assets

August 17, 2023

Medical Devices

A newly formed subsidiary of Bimini Health Tech acquired substantially all assets of Ideal Implant, Inc., including intellectual property, regulatory approvals (FDA Class III for the breast implant), inventory and certain manufacturing capacity. The acquisition adds the Serene Breast Implant to Bimini’s plastic and reconstructive surgery portfolio and is intended to reposition the technology for the hospital setting to drive growth.